Management of the axilla in breast cancer patients undergoing neoadjuvant therapy
White, J.
Clinical Advances in Hematology and Oncology H&o 11(12): 796-798
2013
ISSN/ISBN: 1543-0790 PMID: 24893284 Document Number: 671369
Document emailed within 1 workday
Related Documents
Arimappamagan, A.; Kadambari, D.; Srinivasan, K.; Krishnan, R.; Elangovan, S.; Reddy, K.S.N. 2004: Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: a step towards conserving axilla? Indian Journal of Cancer 41(1): 13-17Aziz, H.; Zeeshan, M.; Jie, T.; Maegawa, F.B. 2019: Neoadjuvant Chemoradiation Therapy Is Associated with Adverse Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer American Surgeon 85(11): 1276-1280
Shahzad, R.; Masood, M.; Shahid, A.; Mirza, Z.R.; Cheema, F.E.; Fatima, I. 2019: Sonographically guided metalic clip placement for tumour localization in early breast cancer patients undergoing neoadjuvant chemotherapy JPMA. Journal of the Pakistan Medical Association 69(10): 1501-1504
Johnke, R.M.; Edwards, J.M.; Evans, M.J.; Nangami, G.N.; Bakken, N.T.G.; Kilburn, J.M.; Lee, T.-K.; Allison, R.R.; Karlsson, U.L.; Arastu, H.H. 2009: Circulating cytokine levels in prostate cancer patients undergoing radiation therapy: influence of neoadjuvant total androgen suppression In Vivo 23(5): 827-833
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Van Schalkwyk, L.; Benn, C.; Bergstrom, K. 2017: Surgery Post Neoadjuvant Therapy for Breast Cancer: An Analysis of 82 Patients Treated at a Specialist Unit in Johannesburg South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 55(3): 75
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Semiglazov, V.F.; Semiglazov, V.V.; Petrenko, O.L.; Komyakhov, A.V.; Dashyan, G.A.; Paltuev, R.M.; Semiglazova, T.Y.; Manikhas, A.G.; Bozhok, A.A.; Lalak, I.A. 2015: Breast-Conserving Surgery after Neoadjuvant Therapy for Breast Cancer Voprosy Onkologii 61(3): 381-386
Ogawa, Y.; Aono, T.; Yamada, T.; Nishikawa, K.; Ikeda, K.; Tokunaga, S.; Okawa, K.; Ikehara, T. 2010: Evaluation of liaison-clinical pathway for patients with breast cancer undergoing adjuvant therapy after curative operation--data from questionnaire survey of 56 clinics and 105 patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(8): 1477-1481
Schneeweiss, A.; Bastert, G.; Huober, J.; Wallwiener, D.; Hamerla, R.; Lichter, P. 2004: Neoadjuvant therapy with gemcitabine in breast cancer Oncology 18(14 Suppl 12: 27-31
Makino, H.; Iraha, M.; Manba, N.; Hashidate, H.; Shiotani, M. 2012: Utility of serum human epidermal growth factor receptor-2 extracellular domain(HER2 ECD)assessment in patients with advanced or recurrent breast cancer and those who received neoadjuvant therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(2): 237-240
Neola, B.; Puppio, B.; Marino, G.; La Torre, G. 2019: Is it always necessary to perform an axillary lymph node dissection on patients undergoing neoadjuvant therapy? Outcomes of a retrospective study Annali Italiani di Chirurgia 90: 292-296
Voznyĭ, E.K.; Gurov, S.N.; Dobrovol'skaia, N.I. 2001: Certain aspects of neoadjuvant therapy of locally advanced breast cancer Voprosy Onkologii 47(6): 690-694
Sautter-Bihl, M.L. 2000: Does neoadjuvant therapy promote or delay metastasis in breast cancer? Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(6): 291-292
Voznyĭ, E.K.; Gurov, S.N.; Dobrovol'skaia, N.I. 2001: Certain aspects of neoadjuvant therapy of locally advanced breast cancer Voprosy Onkologii 47(6): 690-694
Kahraman, K.; Pabuccu, E.; Taskin, S.; Sukur, Y.E.; Ozmen, B.; Ortac, F. 2011: The role of ultrasound and symptom-based triage for detection of pathological endometrial changes in patients undergoing tamoxifen therapy for breast cancer European Journal of Gynaecological Oncology 32(6): 667-671
Fonseca, E.; Cruz, J.J.; Dueñas, A.; Gómez, A.; Sánchez, P.; Martín, G.; Nieto, A.; Soria, P.; Muñoz, A.; Gómez, J.L.; Pardal, J.L. 1996: Do the conventional clinicopathologic parameters predict for response and survival in head and neck cancer patients undergoing neoadjuvant chemotherapy? Tumori 82(6): 560-566
Von Minckwitz, G.; Loibl, S.; Untch, M. 2012: What is the current standard of care for anti-HER2 neoadjuvant therapy in breast cancer? Oncology 26(1): 20-26
Inafuku, K.; Inari, H.; Goto, N.; Kawamoto, M.; Hatori, S.; Tanabe, H.; Masuda, M. 2014: A case of postmenopausal breast cancer becoming HER2 positive after neoadjuvant hormone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(4): 487-489
Konishi, K.; Hasegawa, N.; Kaneko, H.; Iimura, Y.; Shoji, Y.; Kawabata, M. 2010: A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 111-113